Literature DB >> 23035229

Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytes.

Sandip K Bose1, Keith Meyer, Adrian M Di Bisceglie, Ratna B Ray, Ranjit Ray.   

Abstract

Hepatitis C virus (HCV)-mediated liver disease progression may reflect distinct molecular mechanisms for increased hepatocyte growth and hepatic stellate cell activation. In this study, we have observed that primary human hepatocytes, when infected in vitro with cell culture-grown HCV genotype 1a or 2a, display viral RNA and protein expression. Infected hepatocytes displayed a fibroblast-like shape and an extended life span. To understand the changes at the molecular level, we examined epithelial-mesenchymal transition (EMT) markers. Increased mRNA and protein expression levels of vimentin, snail, slug, and twist and a loss of the epithelial cell marker E-cadherin were observed. Snail and twist, when examined separately, were upregulated in chronically HCV-infected liver biopsy specimens, indicating an onset of an active EMT state in the infected liver. An increased expression level of fibroblast-specific protein 1 (FSP-1) in the infected hepatocytes was also evident, indicating a type 2 EMT state. Infected hepatocytes had significantly increased levels of phosphorylated β-catenin (Ser(552)) as an EMT mediator, which translocated into the nucleus and activated Akt. The phosphorylation level of β-catenin at Thr(41)/Ser(45) moieties was specifically higher in control than in HCV-infected hepatocytes, implicating an inactivation of β-catenin. Together, these results suggested that primary human hepatocytes infected with cell culture-grown HCV display EMT via the activation of the Akt/β-catenin signaling pathway. This observation may have implications for liver disease progression and therapeutic intervention strategies using inhibitory molecules.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23035229      PMCID: PMC3503076          DOI: 10.1128/JVI.02016-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail.

Authors:  Junichi Ikenouchi; Miho Matsuda; Mikio Furuse; Shoichiro Tsukita
Journal:  J Cell Sci       Date:  2003-03-26       Impact factor: 5.285

2.  Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma.

Authors:  Philippe Merle; Miran Kim; Marc Herrmann; Anand Gupte; Lydie Lefrançois; Sophia Califano; Christian Trépo; Shinji Tanaka; Ludmila Vitvitski; Suzanne de la Monte; Jack R Wands
Journal:  J Hepatol       Date:  2005-06-21       Impact factor: 25.083

Review 3.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

4.  beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation.

Authors:  C Liu; Y Kato; Z Zhang; V M Do; B A Yankner; X He
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

5.  beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.

Authors:  T Brabletz; A Jung; S Dag; F Hlubek; T Kirchner
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 6.  Epidemiology of HCV infection.

Authors:  V Baldo; T Baldovin; R Trivello; A Floreani
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 7.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

8.  A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migration.

Authors:  Garrick K Wilson; Claire L Brimacombe; Ian A Rowe; Gary M Reynolds; Nicola F Fletcher; Zania Stamataki; Ricky H Bhogal; Maria L Simões; Margaret Ashcroft; Simon C Afford; Ragai R Mitry; Anil Dhawan; Christopher J Mee; Stefan G Hübscher; Peter Balfe; Jane A McKeating
Journal:  J Hepatol       Date:  2011-12-16       Impact factor: 25.083

9.  Assembly of the cadherin-catenin complex in vitro with recombinant proteins.

Authors:  H Aberle; S Butz; J Stappert; H Weissig; R Kemler; H Hoschuetzky
Journal:  J Cell Sci       Date:  1994-12       Impact factor: 5.285

10.  Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer.

Authors:  A Arzumanyan; T Friedman; E Kotei; I O L Ng; Z Lian; M A Feitelson
Journal:  Oncogene       Date:  2011-06-27       Impact factor: 9.867

View more
  35 in total

1.  Establishment of a Patient-Derived Xenograft Tumor From Hepatitis C-Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy.

Authors:  Mustafa Nazzal; Subhayan Sur; Robert Steele; Mousumi Khatun; Tapas Patra; Nancy Phillips; John Long; Ranjit Ray; Ratna B Ray
Journal:  Hepatology       Date:  2020-08       Impact factor: 17.425

2.  Hepatitis C virus-induced tumor-initiating cancer stem-like cells activate stromal fibroblasts in a xenograft tumor model.

Authors:  Reina Sasaki; Pradip Devhare; Ratna B Ray; Ranjit Ray
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425

3.  Adenosine A2a Receptor Blockade Diminishes Wnt/β-Catenin Signaling in a Murine Model of Bleomycin-Induced Dermal Fibrosis.

Authors:  Jin Zhang; Carmen Corciulo; Hailing Liu; Tuere Wilder; Mayumi Ito; Bruce Cronstein
Journal:  Am J Pathol       Date:  2017-06-28       Impact factor: 4.307

Review 4.  Mechanisms of hepatocarcinogenesis in chronic hepatitis C.

Authors:  Jonathan K Mitchell; David R McGivern
Journal:  Hepat Oncol       Date:  2014-09-09

5.  Epithelial-mesenchymal transition in cancer: Role of the IL-8/IL-8R axis.

Authors:  Zhiwei Zhao; Shichao Wang; Yingbo Lin; Yali Miao; Ye Zeng; Yongmei Nie; Peng Guo; Guangyao Jiang; Jiang Wu
Journal:  Oncol Lett       Date:  2017-04-13       Impact factor: 2.967

6.  Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes.

Authors:  Young-Chan Kwon; Sandip K Bose; Robert Steele; Keith Meyer; Adrian M Di Bisceglie; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

7.  Dysregulation of the cohesin subunit RAD21 by Hepatitis C virus mediates host-virus interactions.

Authors:  Shira Perez; Michael Gevor; Ateret Davidovich; Antony Kaspi; Katreena Yamin; Tom Domovich; Tomer Meirson; Avi Matityahu; Yehuda Brody; Salomon M Stemmer; Assam El-Osta; Izhak Haviv; Itay Onn; Meital Gal-Tanamy
Journal:  Nucleic Acids Res       Date:  2019-03-18       Impact factor: 16.971

8.  Elevation of Plasminogen Activator Inhibitor-1 promotes differentiation of Cancer Stem-like Cell state by Hepatitis C Virus infection.

Authors:  Da-Eun Nam; Angelina Angelucci; Dahsom Choi; Arnold Leigh; Hae Chang Seong; Young S Hahn
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

Review 9.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

Review 10.  Mechanisms of HCV-induced liver cancer: what did we learn from in vitro and animal studies?

Authors:  Ivan Rusyn; Stanley M Lemon
Journal:  Cancer Lett       Date:  2013-07-18       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.